Drug-labels.com Search Menu

Alecensaro: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Facts
Strength:
150 mg
ATC code:
Similar drugs:

Patient Medication Information: uses, side effects, how to take - Alecensaro

Serious warnings and precautions box

What ALECENSARO is used for:

ALECENSARO is used:

  • to treat adult patients with anaplastic lymphoma kinase (ALK)-positive, locally advanced (a cancer that cannot be surgically removed or treated with chemotherapy or radiation for cure) or metastatic (a cancer that has spread to other parts of the body) non-small cell lung cancer (NSCLC) who have gotten worse on or are unable to take crizotinib.
  • as the first treatment option for your locally advanced or metastatic ALK positive non-small cell lung cancer.
  • as treatment for ALK-positive non-small cell lung cancer after the tumour has been removed by surgery.

How ALECENSARO works:

ALECENSARO belongs to a group of anti-tumour medicines which stop cancer from making new cells if the cancer is caused by a defect in a gene called anaplastic lymphoma kinase (ALK). By doing so, ALECENSARO may slow down the growth and spread of non-small cell lung cancer (NSCLC).

  • Serious side effects with ALECENSARO include:

    • Life-threatening tear in the stomach or intestine (gastrointestinal perforation)
    • Liver problems
    • Lung problems
    • Slow heart beat
  • ALECENSARO has not been studied in patients with severe kidney problems.
  • ALECENSARO should only be prescribed and used under the supervision of a healthcare professional experienced with drugs used to treat cancer.

The ingredients in ALECENSARO are:

Medicinal ingredient: alectinib (as alectinib hydrochloride)

Non-medicinal ingredients: carboxymethylcellulose calcium, carnauba wax, carrageenan, corn starch, hydroxypropylcellulose, hypromellose, lactose monohydrate, magnesium stearate, potassium chloride, sodium lauryl sulfate, titanium dioxide and traces of printing ink.

ALECENSARO comes in the following dosage form:

Capsules: 150 mg alectinib (white, with “ALE” printed in black ink on the cap and “150 mg” printed in black ink on the body).

Do not use ALECENSARO if:

  • you are allergic to alectinib or any of the other ingredients in ALECENSARO

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take ALECENSARO. Talk about any health conditions or problems you may have, including if you:

  • are intolerant to lactose, as ALECENSARO contains lactose.
  • are younger than 18 years of age. The effects of ALECENSARO in people younger than 18 years old are not known.
  • are 65 years of age or older. There might be a higher chance of side effects.
  • are taking medicine to lower your blood pressure or control your heart rate.
  • have serious liver problems. This is because your starting dose of ALECENSARO may need to be lowered.
  • have serious kidney problems.
  • have or have had pancreas problems.
  • have a history of slow heart rate or fainting.
  • have a history of heart problems including irregular heartbeat, heart disease and heart failure.
  • have a history of problems with your gut, such as inflammation in the intestines (diverticulitis), a previous tear in your stomach or intestines or cancer that has spread to your gut.
  • have high fat (triglyceride) levels in your blood.

Other warnings you should know about:

  • Serious Lung Problems: ALECENSARO may cause severe or life-threatening swelling of the lungs during treatment. The signs may be similar to those from your lung cancer.
  • Sensitivity to Sunlight:

    • ALECENSARO can cause your skin to become very sensitive to sunlight.
    • You should limit your exposure to the sun and tanning beds while you are taking ALECENSARO and for 7 days after stopping.
    • If you cannot avoid sun exposure, you must use a broad spectrum UVA/UVB sunscreen and lip balm to protect against sunburn.
  • Check-ups and testing: You will have regular visits with your healthcare professional before and during treatment with ALECENSARO to monitor your health. They will:

    • monitor your heart rate and blood pressure at baseline and regularly during treatment.
    • do blood tests to check:

      • calcium and potassium levels
      • your liver health. ALECENSARO may cause serious liver problems, including liver injury. Your healthcare professional will do blood tests before you start treatment, then every 2 weeks for the first 3 months of your treatment and then less often.
      • for signs of muscle problems. Muscle problems are very common with ALECENSARO and can be severe. Your healthcare professional will do blood tests at least every 2 weeks for the first month and as needed during treatment. Tell your healthcare professional right away if you get new or worsening signs and symptoms of muscle problems.
      • blood triglyceride levels. Triglycerides are the most common type of fat in the blood. ALECENSARO may cause severe increases in blood fat levels. This may lead to pancreatitis (inflammation of the pancreas) which can be life-threatening.
  • Female patients:

    Pregnancy and breastfeeding

    • If you are pregnant or plan on becoming pregnant, there are specific risks you should discuss with your healthcare professional.
    • Do NOT become pregnant while taking ALECENSARO, as it can harm your unborn baby.
    • If you are able to become pregnant:

      • You must use effective birth control during treatment and for at least 5 weeks after stopping ALECENSARO. Talk to your healthcare professional about birth control methods that may be right for you.
      • Tell your healthcare professional right away if you become pregnant during treatment with ALECENSARO.

Breast-feeding

  • Do NOT breast-feed while taking ALECENSARO. It is not known if ALECENSARO passes into your breast milk.
  • Talk to your healthcare professional about the best way to feed your baby during treatment with ALECENSARO.
  • Male patients:
  • If you are a male patient with a female partner who is able to become pregnant:

    • You should use effective birth control during treatment and for at least 3 months after stopping ALECENSARO.
    • Tell your healthcare professional right away if your partner becomes pregnant while you are receiving treatment with ALECENSARO
  • Fertility:
  • It Is not known if ALECENSARO affects your ability to have children. Talk to your healthcare professional if this is a concern for you.
  • Driving or using machines: ALECENSARO may influence your ability to drive and use machines. If you feel dizzy, weak, or tired, or have problems with your eyes while taking ALECENSARO, do not drive or use tools or machines.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with ALECENSARO:

  • Digoxin, used for heart problems
  • Dabigatran, used to thin the blood to prevent blood clots
  • Methotrexate, used to treat cancer and immune system disorders
  • Drugs used to lower heart rate
  • St. John’s wort, a herbal medicine used to treat depression
  • Grapefruit, grapefruit juice, products containing grapefruit extract, star fruit, pomegranate, Seville oranges or other similar fruit

How to take ALECENSARO:

  • Always take ALECENSARO exactly as your healthcare professional has told you. Check with your healthcare professional if you are not sure.
  • ALECENSARO is taken by mouth. Swallow each capsule whole. Do not open or dissolve the capsules.
  • You should take ALECENSARO with food.

Usual dose:

  • The recommended dose of ALECENSARO is 600 mg (4 capsules) taken twice daily.
  • This means you are taking a total of 1200 mg (8 capsules) per day.

Sometimes your healthcare professional may lower your dose, stop your treatment for a short time or stop your treatment completely if you feel unwell.

Overdose:

If you think you, or a person you are caring for, have taken too much ALECENSARO, contact a healthcare professional, hospital emergency department, regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

Missed dose:

If you forget to take ALECENSARO:

  • Take your next dose at your regular time.
  • Do not take a double dose to make up for a missed dose.

Vomiting:

If you vomit (throw up) after taking ALECENSARO, do not take an extra dose of ALECENSARO, just take your next dose at the usual time.

Possible side effects from using ALECENSARO:

These are not all the possible side effects you may have when taking ALECENSARO. If you experience any side effects not listed here, tell your healthcare professional. Please also see the warnings above.

  • constipation
  • diarrhea
  • nausea
  • vomiting
  • abnormal or metallic taste in the mouth
  • inflammation of the mucous membrane of the mouth
  • weight gain
  • headache
  • dizziness
  • sensitivity to sunlight
  • problems with your eyes such as blurred vision, loss of sight, black dots or white spots in your vision, and seeing double.
  • dry skin
  • rash
  • hair loss
  • itching
  • numbness and tingling in the hands and feet
  • muscle ache and pain, joint pain
  • fatigue
  • swelling caused by fluid build-up in the body (edema)

ALECENSARO can cause abnormal blood test results, including increased level of uric acid (hyperuricemia). Your healthcare professional will decide when to perform blood tests and will interpret the results.

Serious side effects and what to do about them

Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Only if severeIn all cases
Only if severeIn all cases
Common
Serious Muscle Problems: unexplained muscle pain or muscle pain that does not go away, tenderness, or weakness
Serious Anemia (decreased number of red blood cells): fatigue, dizziness, fast heart rate, shortness of breath
Serious Lung Problems: new or worsening difficulty breathing, shortness of breath, cough with or
without mucous, fever, chest pain when you breath or cough, fatigue.
Slow Heart Beat: dizziness, lightheadedness, slow heart beat, fainting, abnormal heartbeats
Hypertriglyceridemia (severe increase in blood triglycerides), as seen on blood tests. This may lead to Life-threatening Pancreatitis (inflammation of the pancreas): Symptoms of pancreatitis include sudden, severe abdominal pain accompanied by nausea, vomiting, fast heart rate, fast breathing and/or fever.
Uncommon
Life-threatening Tear in the Stomach or Intestines: severe stomach or abdominal pain, fever, chills, or changes in bowel habits, death.
Serious Liver Problems: yellowing of your skin or the whites of your eyes, pain on the right side of your stomach area, dark urine, itchy skin, feeling tired, feeling less hungry than usual, nausea or vomiting, bleeding or bruising more easily than normal.
Serious Kidney Problems: change in the amount or colour of your urine, new or worsening swelling in your legs or feet.
Very rare
Hemolytic anemia (breakdown of red blood cells): pale skin, feeling tired or weak, dizziness, thirst, rapid breathing

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting side effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

  • Store ALECENSARO between 15-30°C.
  • Store in the original package in order to protect from light and moisture.
  • Keep out of reach and sight of children.
  • Do not take this medicine after the expiry date which is stated on the bottle after “EXP”. The expiry date refers to the last day of that month.
  • Do not throw away any unused medicine in the garbage or down the drain or toilet. Therefore, ask your pharmacist how to best dispose of medicines that you no longer require. These measures will help to protect the environment.

If you want more information about ALECENSARO:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes the Patient Medication Information by visiting the Health Canada Drug Product Database website https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html; the manufacturer’s website www.rochecanada.com; or by calling 1-888-762-4388.

Date of Authorization: 2026-07-17

©Copyright 2026, Hoffmann-La Roche Limited

ALECENSARO® is a registered trademark of Chugai Seiyaku Kabushiki Kaisha, used under license.

All other trademarks are the property of their respective owners.

Hoffmann-La Roche Limited

Mississauga, ON L5N 5M8

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02458136

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Alecensaro

Rx or OTC
Prescription (Rx)?
DIN 02458136
Schedule(s) PRESCRIPTION
Active ingredient(s) Alectinib (alectinib hydrochloride) 150 MG
Dosage form(s) Capsule
Route(s) of administration Oral
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L01 Antineoplastic agents
      1. L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents
        1. L01ED Anaplastic lymphoma kinase (ALK) inhibitors
          1. L01ED03 Alectinib
Company HOFFMANN-LA ROCHE LIMITED
Current status Marketed
Current status date October 14, 2016

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.